Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tinley Beverage Company Inc C.TNY

Alternate Symbol(s):  TNYBF

The Tinley Beverage Company Inc., together with its subsidiaries, manufactures a line of non-alcoholic, cannabis-infused beverages for use in California, United States and in Ontario, Canada. The Company also manufactures cannabis-infused beverages for contract manufacturing clients. It offers terpene and cannabis-infused non-alcoholic Tinley's '27 and Tinley's Tonics products, for distribution to licensed dispensaries and home delivery channels in California. The Beckett's Classics and Beckett's '27 lines of non-alcoholic, terpene-infused non-cannabis versions of these formulations are available in select mainstream food, beverage, and specialty retailers in the United States as well as in select grocery and specialty stores in Canada. Its subsidiaries include Hemplify Inc., Algonquin Springs Beverage Management LLC, Beckett’s Tonics California Inc., Beckett's Tonics Canada Inc., Tinley's Canada Inc., and Lakewood Libations Inc.


CSE:TNY - Post by User

Bullboard Posts
Comment by Reyninakon Apr 17, 2018 1:36pm
59 Views
Post# 27898785

RE:Drug Made from Cannabis Plant gets Backing from FDA Staff

RE:Drug Made from Cannabis Plant gets Backing from FDA StaffThanks for sharing! This is another piece of great news as it shows more openness to the idea of cannabis broad use. I tend to think that de/rescheduling might happen way quicker than we think. It might be naivet or wishful thinking...
NedStark wrote: This is something to keep your eye on in June. If Epidiolex gets approved by the FDA then marijuana’s schedule 1 status will have to be changed immediately.

https://www.bloomberg.com/news/articles/2018-04-17/drug-made-from-cannabis-plant-gets-backing-from-fda-staff



Bullboard Posts